Drugs / stem cell therapy
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT06132542 | Jan → Oct 2024 | primary ovarian failure | Mongolian National University of Medical Sciences | Unknown | No outcome recorded |
| Phase 1 | NCT00535548 | Jan → Dec 2007 | decubitus ulcer | University Hospital, Basel, Switzerland | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT05658692 | Oct 2022 → Oct 2023 | acute respiratory distress syndrome | Second Affiliated Hospital, School of Medicine, Zhejiang University | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00418418 Comparator | Oct 2006 → Dec 2009 | coronary artery disorder, myocardial infarction, systolic heart failure | University of Helsinki | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | stem cell therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06132542 ↗ |
| Known as | Intramyocardial mesenchymal stem cell transplantation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00418418 ↗ |
| Action | Restore | “We are planning to investigate the effectiveness of adipose stem cell on ovarian tissue regeneration for patients with premature ovarian failure.” NCT06132542 ↗ |
| Modality | Cell therapy | “mesenchymal stem cell transplantation” NCT00418418 ↗ |
| Route | Other | “stem cells are directly injected to myocardium” NCT00418418 ↗ |